1. Home
  2. GBIO vs IONR Comparison

GBIO vs IONR Comparison

Compare GBIO & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • IONR
  • Stock Information
  • Founded
  • GBIO 2016
  • IONR 2001
  • Country
  • GBIO United States
  • IONR Australia
  • Employees
  • GBIO N/A
  • IONR N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • IONR
  • Sector
  • GBIO Health Care
  • IONR
  • Exchange
  • GBIO Nasdaq
  • IONR Nasdaq
  • Market Cap
  • GBIO 187.5M
  • IONR 171.1M
  • IPO Year
  • GBIO 2020
  • IONR N/A
  • Fundamental
  • Price
  • GBIO $2.86
  • IONR $5.00
  • Analyst Decision
  • GBIO Buy
  • IONR
  • Analyst Count
  • GBIO 4
  • IONR 0
  • Target Price
  • GBIO $7.50
  • IONR N/A
  • AVG Volume (30 Days)
  • GBIO 77.3K
  • IONR 9.4K
  • Earning Date
  • GBIO 11-07-2024
  • IONR 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • IONR N/A
  • EPS Growth
  • GBIO N/A
  • IONR N/A
  • EPS
  • GBIO N/A
  • IONR N/A
  • Revenue
  • GBIO $13,174,000.00
  • IONR N/A
  • Revenue This Year
  • GBIO $99.36
  • IONR N/A
  • Revenue Next Year
  • GBIO N/A
  • IONR N/A
  • P/E Ratio
  • GBIO N/A
  • IONR N/A
  • Revenue Growth
  • GBIO 1397.05
  • IONR N/A
  • 52 Week Low
  • GBIO $0.86
  • IONR $2.90
  • 52 Week High
  • GBIO $4.65
  • IONR $6.50
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 58.55
  • IONR 70.12
  • Support Level
  • GBIO $2.41
  • IONR $4.14
  • Resistance Level
  • GBIO $2.63
  • IONR $4.67
  • Average True Range (ATR)
  • GBIO 0.21
  • IONR 0.36
  • MACD
  • GBIO 0.05
  • IONR 0.06
  • Stochastic Oscillator
  • GBIO 100.00
  • IONR 99.20

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About IONR ioneer Ltd

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S. based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Share on Social Networks: